EDESA BIOTECH INC
EDSA · NASDAQ
Updated at 2026-10-15 08:28:24
- Today's High
- $2.84
- Today’s Low
- $2.62
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.84
- Previous Close
- $2.65
- Volume
- 72.59K
- Market Cap
- $35.8M
- P/E Ratio
- --
- EPS
- $-1.69
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 100 SPY COURT, MARKHAM, ON, CANADA, L3R 5H6
- Country
- CA
- Listing Date
- 2008-08-25
- Fiscal Year End
- September
- Shares Outstanding
- 9.63M
- CIK
- 0001540159
- Website
- www.edesabiotech.com
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$50.91K
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.51M
2026-03-31
$4.27M
2025-12-31
$2.31M
2025-09-30
$2.44M
Net Income
2026-06-30
-$5.4M
2026-03-31
-$4.21M
2025-12-31
-$2.24M
2025-09-30
-$2.22M
Net Profit Margin
2026-06-30
--
2026-03-31
-8.28K%
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.60
2026-03-31
$-0.49
2025-12-31
$-0.28
2025-09-30
$-0.32
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.49M
2026-03-31
-$4.27M
2025-12-31
-$2.31M
2025-09-30
-$2.19M
Effective Tax Rate
2026-06-30
--
2026-03-31
-0.01%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $50.91K | $0 | $0 |
| Operating Expenses | $5.51M | $4.27M | $2.31M | $2.44M |
| Net Income | -$5.4M | -$4.21M | -$2.24M | -$2.22M |
| Net Profit Margin | -- | -8.28K% | -- | -- |
| Earnings Per Share | $-0.60 | $-0.49 | $-0.28 | $-0.32 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.49M | -$4.27M | -$2.31M | -$2.19M |
| Effective Tax Rate | -- | -0.01% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.